Loading...

Hypera S.A.

HYPMY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.35
$0.34(8.48%)

Hypera S.A. (HYPMY) Stock Overview

Explore Hypera S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.3/100

Key Financials

Market Cap2.8B
P/E Ratio20.03
EPS (TTM)$0.21
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Week$4.63
1 Month$4.44
3 Months$2.98
1 Year Target$2.53

HYPMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hypera S.A. (HYPMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.03 and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.15%
5-Day Change
-5.71%
1-Month Change
4.15%
3-Month Change
16.32%
6-Month Change
-31.62%
Year-to-Date (YTD) Change
7.46%
1-Year Change
-44.42%
3-Year Change
-59.27%
5-Year Change
-42.82%
All-Time (Max) Change
-74.98%

Contact Information

https://www.hyperapharma.com.br
55 11 3627 4206
Av. Magalhães de Castro, 4800, São Paulo, SP, 05676-120

Company Facts

10,481 Employees
IPO DateOct 15, 2010
CountryBR
Actively Trading

Frequently Asked Questions

;